Rothschild Investment LLC’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,339
Closed -$219K 417
2017
Q4
$219K Sell
1,339
-10,285
-88% -$1.85M 0.02% 371
2017
Q3
$2.38M Sell
11,624
-399
-3% -$92.8K 0.27% 89
2017
Q2
$2.92M Buy
12,023
+1,369
+13% +$322K 0.33% 75
2017
Q1
$2.54M Buy
10,654
+1,436
+16% +$334K 0.3% 82
2016
Q4
$1.94M Sell
9,218
-3,686
-29% -$764K 0.23% 108
2016
Q3
$2.97M Buy
12,904
+4,507
+54% +$1.1M 0.36% 77
2016
Q2
$1.94M Buy
8,397
+3,234
+63% +$746K 0.25% 109
2016
Q1
$1.38M Buy
+5,163
New +$1.48M 0.18% 136

Other funds holding AGN

Rothschild Investment LLC's AGN Position: Q1 2018 in Review

Rothschild Investment LLC sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 1,339 shares — an estimated $219K sold.

Rothschild Investment LLC first reported a position in AGN in Q1 2016 and held it in 8 quarters. The position peaked at $2.97M in Q3 2016. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Rothschild Investment LLC reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Rothschild Investment LLC sold 1,339 Allergan plc shares in Q1 2018, an estimated $219K.
  • Rothschild Investment LLC first reported a position in Allergan plc in Q1 2016 and held it in 8 quarters.
  • Rothschild Investment LLC's Allergan plc position peaked at $2.97M in Q3 2016.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Rothschild Investment LLC's 13F filing for Q1 2018, filed 27 Apr 2018.